Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v5-EN
Language French English
Date Updated 2018-03-28 2018-03-28
Drug Identification Number 02242986 02242986
Brand name OPTIMARK OPTIMARK
Common or Proper name GADOVERSETAMIDE INJECTION GADOVERSETAMIDE INJECTION
Company Name LIEBEL-FLARSHEIM CANADA INC LIEBEL-FLARSHEIM CANADA INC
Ingredients GADOVERSETAMIDE GADOVERSETAMIDE
Strength(s) 330.9MG 330.9MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5, 10, 15, 20mL vials all packaging size (5, 10, 15, 20mL vials)
ATC code V08CA V08CA
ATC description MAGNETIC RESONANCE IMAGING CONTRAST MEDIA MAGNETIC RESONANCE IMAGING CONTRAST MEDIA
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-12-31 2017-12-31
Actual discontinuation date 2018-03-23 2018-03-23
Remaining supply date 2018-03-23 2017-12-23
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments